AstraZeneca Pharma India Ltd. - Research Center
506820 ASTRAZEN Group (A) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Dec' 24 | Sep' 24 | Jun' 24 | Mar' 24 | Dec' 23 | |
|---|---|---|---|---|---|
| Sales | 440.29 | 408.00 | 387.52 | 383.20 | 305.79 |
| Operating profit | 76.99 | 52.54 | 38.08 | 49.39 | 15.06 |
| Interest | 0.33 | 0.34 | 0.11 | -0.07 | 0.61 |
| Gross profit | 84.64 | 60.35 | 46.32 | 58.12 | 24.10 |
| EPS (Rs) | 12.34 | 15.37 | -4.72 | 15.79 | 6.32 |
Quarterly
results in details
| Dec' 24 | Sep' 24 | Jun' 24 | Mar' 24 | Dec' 23 | |
|---|---|---|---|---|---|
| Other income | 7.98 | 8.15 | 8.35 | 8.66 | 9.66 |
| Stock adjustment | -51.61 | -103.09 | -55.74 | 104.95 | -70.76 |
| Raw material | 69.88 | 77.15 | 45.85 | 33.62 | 37.52 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 62.37 | 68.04 | 60.96 | 57.98 | 63.23 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | 22.74 | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 260.09 | 313.36 | 298.36 | 137.26 | 260.74 |
| Provisions made | -0.17 | - | - | - | - |
| Depreciation | 9.07 | 9.32 | 3.91 | 3.76 | 3.70 |
| Taxation | 11.17 | 12.60 | -3.37 | 14.88 | 4.60 |
| Net profit / loss | 30.85 | 38.43 | -11.79 | 39.48 | 15.80 |
| Extra ordinary item | -33.55 | - | -57.56 | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 17.49 | 12.88 | 9.83 | 12.89 | 4.92 |
| GPM (%) | 18.88 | 14.50 | 11.70 | 14.83 | 7.64 |
| NPM (%) | 6.88 | 9.23 | -2.98 | 10.07 | 5.01 |
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis